EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The tumor microenvironment in lung cancer: Heterogeneity, therapeutic resistance and emerging treatment strategies (Review)

Li Liu, Li Yang, Hongmin Li, Tianlu Shang, Lihan Liu

International Journal of Oncology · 26.11.2025 · 68 (1) · 1-16

DOI: 10.3892/ijo.2025.5824 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 26.11.2025. Verfasst von Li Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, Gansu 730900, P.R. China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Lung Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer remains a leading cause of cancer‑related death. Despite advances in targeted therapies and immunotherapy, treatment outcomes remain suboptimal due to tumor heterogeneity and therapeutic resistance. The tumor microenvironment (TME), a dynamic ecosystem comprising immune cells, stromal components, extracellular matrix and bioactive molecules, serves a critical role in promoting tumor progression and resistance. The present review comprehensively analyzes the molecular mechanisms underlying TME‑mediated immune evasion, and resistance to chemotherapy, radiotherapy and immunotherapy. In addition, emerging therapeutic strategies targeting the TME are highlighted, such as immune microenvironment modulation, metabolic and epigenetic interventions, and nanotechnology‑based drug delivery systems. By integrating multi‑omics datasets and spatial transcriptomics, TME‑directed interventions are moving toward biomarker‑guided, personalized regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentLung NeoplasmsDrug Resistance, NeoplasmHumansImmunotherapyTumor Escape

Stichwörter der Autor:innen

clinical applicationepigenetic modulationimmune evasionlung cancermetabolic reprogrammingtherapeutic resistancetherapeutic strategiestumor microenvironment

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, Gansu 730900, P.R. China.
  • Department of Oncology, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, Gansu 730900, P.R. China.

Zitieren

APA

Liu, L., Yang, L., Li, H., Shang, T., & Liu, L. (2025). The tumor microenvironment in lung cancer: Heterogeneity, therapeutic resistance and emerging treatment strategies (Review). International Journal of Oncology, 68(1), 1-16. https://doi.org/10.3892/ijo.2025.5824

Vancouver

Liu L, Yang L, Li H, Shang T, Liu L. The tumor microenvironment in lung cancer: Heterogeneity, therapeutic resistance and emerging treatment strategies (Review). International Journal of Oncology. 2025;68(1):1-16. doi:10.3892/ijo.2025.5824

BibTeX
@article{Liu2025,
  author = {Liu, Li and Yang, Li and Li, Hongmin and Shang, Tianlu and Liu, Lihan},
  title = {The tumor microenvironment in lung cancer: Heterogeneity, therapeutic resistance and emerging treatment strategies (Review)},
  journal = {International Journal of Oncology},
  year = {2025},
  volume = {68},
  number = {1},
  pages = {1--16},
  doi = {10.3892/ijo.2025.5824}
}
Kostenlos starten →